Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy

BACKGROUND: The use of methotrexate-acitretin (MTX-ACI) combination therapy in treating psoriasis has been limited due to concerns related to hepatic fibrosis. However, in vitro evidence revealed a protective effect of acitretin in methotrexate (MTX)-induced liver fibrosis. OBJECTIVE: This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattanakaemakorn, Ploysyne, Pinyowiwat, Prinpat, Iamsumang, Wimolsiri, Chanprapaph, Kumutnart, Suchonwanit, Poonkiat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170124/
https://www.ncbi.nlm.nih.gov/pubmed/34093007
http://dx.doi.org/10.2147/DDDT.S304168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170124/
https://www.ncbi.nlm.nih.gov/pubmed/34093007
http://dx.doi.org/10.2147/DDDT.S304168

Ejemplares similares